Nasdaq Stockholm Welcomes Iconovo to First North
Stockholm, April 6, 2018— Nasdaq (Nasdaq: NDAQ) announces that the trading in Iconovo AB’s shares (short name: ICO) will commence today on Nasdaq First North in Stockholm. Iconovo belongs to the health care sector and is the 20th company to be admitted to trading on Nasdaq’s Nordic markets* in 2018.
Founded in 2013, Iconovo is a Swedish company developing proprietary inhalation products for licensing to customers. The company has long and unique experience and capability in the development of inhalation devices and formulations, and its complete inhalation solutions combine technical complexity with user-friendly and attractive design. Iconovo’s ambition is to become a leading supplier of inhalation devices on a global market. For more information, please visit www.iconovo.se.
“I would like to welcome all new shareholders to Iconovo,” said Dr. Orest Lastow, CEO of Iconovo. “My team and I are exited and would like to thank you for the trust and opportunity you have given us. We will work hard to deliver on our promises. We are very excited to become a part of Nasdaq First North and look forward to working together.”
”We welcome Iconovo to Nasdaq First North, where it will join our strong health care sector,” said Adam Kostyál, SVP and Head of European Listings, Nasdaq. “We congratulate Iconovo on its successful listing, and look forward to supporting them with the investor exposure and visibility that comes with a Nasdaq First North listing.”
Iconovo AB has appointed Erik Penser Bank AB as the Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.